Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 10 studies | 34% ± 11% | |
pericyte | 10 studies | 28% ± 12% | |
glutamatergic neuron | 9 studies | 47% ± 22% | |
GABAergic neuron | 7 studies | 37% ± 14% | |
retinal cone cell | 6 studies | 58% ± 21% | |
cardiac muscle cell | 4 studies | 31% ± 2% | |
myofibroblast cell | 4 studies | 22% ± 3% | |
interneuron | 4 studies | 49% ± 26% | |
neuron | 3 studies | 19% ± 3% | |
endothelial cell | 3 studies | 24% ± 7% | |
smooth muscle cell | 3 studies | 25% ± 8% | |
retina horizontal cell | 3 studies | 23% ± 3% | |
granule cell | 3 studies | 29% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 98% | 641.44 | 240 / 245 | 98% | 47.30 | 490 / 502 |
lung | 99% | 623.01 | 574 / 578 | 75% | 4.04 | 862 / 1155 |
intestine | 94% | 312.96 | 907 / 966 | 73% | 4.31 | 384 / 527 |
stomach | 83% | 199.40 | 298 / 359 | 83% | 5.97 | 238 / 286 |
breast | 99% | 547.74 | 456 / 459 | 66% | 4.52 | 737 / 1118 |
bladder | 100% | 604.86 | 21 / 21 | 56% | 3.31 | 281 / 504 |
esophagus | 75% | 246.62 | 1085 / 1445 | 80% | 4.95 | 146 / 183 |
uterus | 99% | 969.94 | 168 / 170 | 46% | 5.07 | 213 / 459 |
adrenal gland | 73% | 146.90 | 189 / 258 | 71% | 10.51 | 164 / 230 |
skin | 86% | 1017.60 | 1561 / 1809 | 47% | 3.00 | 223 / 472 |
kidney | 66% | 169.18 | 59 / 89 | 50% | 3.11 | 453 / 901 |
pancreas | 26% | 40.80 | 85 / 328 | 87% | 5.42 | 154 / 178 |
ovary | 75% | 336.59 | 135 / 180 | 37% | 2.12 | 158 / 430 |
thymus | 95% | 304.40 | 623 / 653 | 15% | 0.48 | 90 / 605 |
brain | 61% | 143.32 | 1620 / 2642 | 39% | 1.95 | 273 / 705 |
blood vessel | 100% | 946.73 | 1333 / 1335 | 0% | 0 | 0 / 0 |
heart | 95% | 307.01 | 814 / 861 | 0% | 0 | 0 / 0 |
adipose | 93% | 527.93 | 1119 / 1204 | 0% | 0 | 0 / 0 |
muscle | 87% | 360.25 | 700 / 803 | 0% | 0 | 0 / 0 |
spleen | 73% | 145.23 | 175 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 56% | 4.89 | 25 / 45 |
lymph node | 0% | 0 | 0 / 0 | 28% | 1.33 | 8 / 29 |
liver | 4% | 5.92 | 8 / 226 | 17% | 0.59 | 68 / 406 |
eye | 0% | 0 | 0 / 0 | 1% | 0.04 | 1 / 80 |
peripheral blood | 1% | 1.34 | 9 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0045727 | Biological process | positive regulation of translation |
GO_0045793 | Biological process | positive regulation of cell size |
GO_0005515 | Molecular function | protein binding |
Gene name | PRR16 |
Protein name | Proline rich 16 Protein Largen (Mesenchymal stem cell protein DSC54) (Proline-rich protein 16) |
Synonyms | |
Description | FUNCTION: Regulator of cell size that promotes cell size increase independently of mTOR and Hippo signaling pathways. Acts by stimulating the translation of specific mRNAs, including those encoding proteins affecting mitochondrial functions. Increases mitochondrial mass and respiration. . |
Accessions | ENST00000446965.2 Q569H4 ENST00000407149.7 [Q569H4-1] ENST00000505123.5 [Q569H4-2] ENST00000379551.2 [Q569H4-3] D6RGF0 ENST00000509923.1 A0A0A0MSW7 |